is a topic covered in the Johns Hopkins HIV Guide
To view the entire topic, please sign in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
Rilpivirine in combination with other ARVs is indicated for the treatment of HIV-1 infection in ART-naïve patients with HIV-1 RNA < 100,000 copies/mL.
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: April 8, 2019
Smith, Janessa M, and Paul Pham. "Rilpivirine." Johns Hopkins HIV Guide, 2019. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545229/all/Rilpivirine.
Smith JM, Pham P. Rilpivirine. Johns Hopkins HIV Guide. 2019. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545229/all/Rilpivirine. Accessed June 18, 2019.
Smith, J. M., & Pham, P. (2019). Rilpivirine. In Johns Hopkins HIV Guide. Available from https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545229/all/Rilpivirine
Smith JM, Pham P. Rilpivirine [Internet]. In: Johns Hopkins HIV Guide. ; 2019. [cited 2019 June 18]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545229/all/Rilpivirine.
TY - ELEC
T1 - Rilpivirine
ID - 545229
A1 - Smith,Janessa, PharmD, BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2019/04/08/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545229/all/Rilpivirine
DB - Johns Hopkins Guide
DP - Unbound Medicine